Acalabrutinib in chronic lymphocytic leukemia therapy: literature review and experience of the Clinical and Diagnostic Center of the Lapino Clinical hospital

Yu. E. Ryabukhina; P. A. Zeynalova

MD-Onco

ISSN 2782-3202 (Print)
ISSN 2782-6171 (Online)

User

eng | рус

MD-Onco

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Ryabukhina Yu.E., Zeynalova P.A. Acalabrutinib in chronic lymphocytic leukemia therapy: literature review and experience of the Clinical and Diagnostic Center of the Lapino Clinical hospital. MD-Onco. 2024;4(3):50-60. (In Russ.) https://doi.org/10.17650/2782-3202-2024-4-3-50-60

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2782-3202 (Print)
ISSN 2782-6171 (Online)

Editor-in-Chief

Davydov Mikhail M.

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

Yu. E. Ryabukhina
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
Russian Federation

Yulia Evgenyevna Ryabukhina

143081; 111 1^st Uspenskoe Shosse; Moscow region; Lapino

P. A. Zeynalova
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

Department of Oncology

143081; 111 1^st Uspenskoe Shosse; Moscow region; Lapino; 119991; Bld. 2, 8 Trubetskaya St.; Moscow

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

MD-Onco

For citations:

Cookies policy